Search results
GSK acquires oligonucleotide drug startup Elsie
BioPharma Dive via Yahoo Finance· 6 days agoOligonucleotides are small strands of DNA or RNA that can be used to craft drugs that alter gene expression. They’re now a well-established class of...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin inhibitor HMPL-506 in
‘The Catalyst’ Review: The RNA Renaissance
The Wall Street Journal· 7 days agoThe unassuming bacteria E. coli, similarly, led to the discovery of the Crispr system that has since been used to develop techniques for gene editing and...
Integrated Bio Developing Transcriptome, Methylation Screens for Small Molecule Drug Discovery
GenomeWeb News· 6 days agoIntegrated Biosciences, a Bay Area startup with ties to the University of California, Santa Barbara, is planning to conduct ultra-high throughput gene expression& ...
Scientists have discovered a cause of inflammatory bowel disease. They said it's a 'holy grail'...
INSIDER via Yahoo News· 6 days agoGetty Images; Chelsea Jia Feng/BI Researchers used genetic editing to uncover a pathway behind...
Building a blueprint of metabolic health—from mouse to human
Medical Xpress· 1 day agoPrevious studies have shown that both genetics and lifestyle influence MetS. Now, scientists led by Johan Auwerx at EPFL have addressed the problem by developing a metabolic health score (MHS ...
CareDx (NASDAQ:CDNA) Stock Price Down 4.1%
ETF DAILY NEWS· 8 hours agoCareDx, Inc (NASDAQ:CDNA – Get Free Report) shares fell 4.1% during trading on Monday . The company traded as low as $14.39 and last traded at $14.59. 176,954 shares changed hands during trading ...
Team reports on synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic...
Medical Xpress· 7 days agoA new research paper titled "Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy" has been published in Oncotarget.
Newswise Expert | Heinz-Josef Lenz, Keck Medicine of USC
Newswise· 3 days agoHeinz-Josef Lenz, M.D., FACP, is the Associate Director for Clinical Research and Co-Leader of the Gastrointestinal Cancers Program at the USC Norris Comprehensive Cancer Center. Dr. Lenz is ...
interFLOW: maximum flow framework for the identification of factors mediating the signaling...
Nature· 2 days agoInitially, we evaluated interFLOW’s performance within a simulation framework, demonstrating the advantages of our proposed method in identifying up-regulated signaling pathways and uncovering ...
